NCT06045819View on ClinicalTrials.gov

Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

January 31, 2026

Conditions

Adult Acute Myeloid Leukemia

Interventions

BIOLOGICAL

Blood sampling for venetoclax drug dosage (venous puncture)

8 blood samples for venetoclax and azole antifungal drugs identification and dosage will be taken by venous and capillary punctures throughout management of patients

Trial Locations (1)

14000

RECRUITING

CHU de Caen, Caen

All Listed Sponsors

lead

University Hospital, Caen

OTHER